Pharmaceuticals(41)
-
Treatment for Drug-Resistant Non-Small Cell Lung Cancer (No. T4-1944)
Non-Small Cell Lung Cancer (NSCLC) is a very common type of cancer, and despite currently available therapies, is one of the deadliest due to the emergence of drug resistance, which results in tumor recurrence. ... Read more6025 -
New Antiviral Drugs from Bacterial Natural Products (No. T4-1934)
The increasing incidence of viral infections across the globe is driving the demand for antiviral drugs. Prof. Rotem Sorek and his team identified a new family of bacterial enzymes that produce various nucleotide analogs with antiviral properties (Bernheim, Nature 2021). ... Read more12514 -
Higher Efficiency of CRISPR Gene Editing Using Chimeric Cas9 (No. T4-1930)
CRISPR-Cas9 is a powerful tool for genome editing, widely used for basic research and the development of treatments for genetic diseases. However, its efficiency is currently limited. ... Read more6024 -
Modulating Protein Degradation through COP9 Signalosome regulation (No. T4-1923)
A potentially therapeutic method to interfere with CSNAP activity, a key negative regulator of protein degradation. ... Read more18406 -
Protein Based Treatment for Duchene Muscular Dystrophy and Cancer (No. T4-1913)
Duchenne muscular dystrophy (DMD) is a disease that affects approximately 1 in 3,500 boys with a life expectancy of ~26 years. ... Read more6026 -
Preventing Biofilm Formation by Enzyme Inhibitors (No. T4-1893)
Biofilm is a complex colony of bacteria, which are attached together by extracellular polymeric substance. This setting provides the bacteria protection against environmental factors, improves their surface attachment, and plays a major role in resistance to treatment. ... Read more5731 -
Universal CAR-Ts for Treating Cancer (No. T4-1884)
Chimeric Antigen Receptor T-Cells (CAR-Ts) are one of the revolutionary technologies of the twenty-first century, invented by Prof. Zelig Eshhar at the Weizmann Institute of Science. ... Read moreZelig Eshhar
Faculty of Biology5722 -
A Platform for Identifying Specific Autophagy Inhibitors for Cancer (No. T4-1883)
Autophagy plays a vital role in the survival of many solid tumors, often leading to drug resistance in chemotherapy and targeted treatments. Prof. ... Read more18497 -
Targeting Novel Regulator for Improved Hematopoietic Stem Cells Generation (No. T4-1874)
A potential method of generating hematopoietic stem cells for transplantation by inhibiting CD74. ... Read more5716 -
Microbiome-Based Prediction, Diagnosis, and Treatment of Relapsing Obesity (No. T4-1805)
A novel method for analyzing the likelihood of weight regain following a weight loss program and maintaining target body weight, based on gut microbiome analysis. ... Read more5659
Pages
